18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?
- PMID: 28102485
- DOI: 10.1007/s11060-016-2366-8
18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?
Abstract
Most high-grade gliomas (HGG) recur after initial multimodal therapy and re-irradiation (Re-RT) has been shown to be a valuable re-treatment option in selected patients. We evaluated the prognostic value of dynamic time-to-peak analysis and early static summation images in O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) PET for patients treated with Re-RT ± concomitant bevacizumab. We retrospectively analyzed 72 patients suffering from recurrent HGG with 18F-FET PET prior to Re-RT. PET analysis revealed the maximal tumor-to-background-ratio (TBRmax), the biological tumor volume, the number of PET-foci and pattern of time-activity-curves (TACs; increasing vs. decreasing). Furthermore, the novel PET parameters early TBRmax (at 5-15 min post-injection) and minimal time-to-peak (TTPmin) were evaluated. Additional analysis was performed for gender, age, KPS, O6-methylguanine-DNA methyltransferase methylation status, isocitrate dehydrogenase 1 mutational status, WHO grade and concomitant bevacizumab therapy. The influence of PET and clinical parameters on post-recurrence survival (PRS) was investigated. Shorter TTPmin was related to shorter PRS after Re-RT with 6 months for TTPmin < 12.5 min, 7 months for TTPmin 12.5-25 min and 11 months for TTPmin >25 min (p = 0.027). TTPmin had a significant impact on PRS both on univariate (p = 0.027; continuous) and multivariate analysis (p = 0.011; continuous). Other factors significantly related to PRS on multivariate analysis were increasing vs. decreasing TACs (p = 0.008) and Karnofsky Performance Score (p = 0.015; <70 vs. ≥70). Early TBRmax as well as the other conventional PET parameters were not significantly related to PRS on univariate analysis. Dynamic 18F-FET PET with TTPmin provides a high prognostic value for recurrent HGG prior to Re-RT, whereas early TBRmax does not. Dynamic 18F-FET PET using TTPmin might help to personalize Re-RT treatment regimens in future through voxelwise TTPmin analysis for dose painting purposes and PET-guided dose escalation.
Keywords: 18F-FET PET; High-grade glioma; Kinetic analysis; Prognostic value; Re-irradiation.
Similar articles
-
Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?J Nucl Med. 2016 Aug;57(8):1177-82. doi: 10.2967/jnumed.115.171033. Epub 2016 Mar 31. J Nucl Med. 2016. PMID: 27033893
-
Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22. Eur J Nucl Med Mol Imaging. 2019. PMID: 30244386
-
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET.Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2581-2589. doi: 10.1007/s00259-019-04477-3. Epub 2019 Aug 13. Eur J Nucl Med Mol Imaging. 2019. PMID: 31410540
-
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.Curr Radiopharm. 2019;12(3):220-228. doi: 10.2174/1874471012666190115124536. Curr Radiopharm. 2019. PMID: 30644351 Review.
-
Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.Acta Neurochir (Wien). 2018 Jul;160(7):1451-1460. doi: 10.1007/s00701-018-3563-3. Epub 2018 May 24. Acta Neurochir (Wien). 2018. PMID: 29797098 Free PMC article.
Cited by
-
Assessment of Brain Tumour Perfusion Using Early-Phase 18F-FET PET: Comparison with Perfusion-Weighted MRI.Mol Imaging Biol. 2024 Feb;26(1):36-44. doi: 10.1007/s11307-023-01861-2. Epub 2023 Oct 17. Mol Imaging Biol. 2024. PMID: 37848641 Free PMC article.
-
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics.Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4415-4425. doi: 10.1007/s00259-021-05526-6. Epub 2021 Sep 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 34490493 Free PMC article. Clinical Trial.
-
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO group.Neuro Oncol. 2021 Jun 1;23(6):881-893. doi: 10.1093/neuonc/noab013. Neuro Oncol. 2021. PMID: 33538838 Free PMC article.
-
Use of static and dynamic [18F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression.EJNMMI Res. 2020 May 29;10(1):56. doi: 10.1186/s13550-020-00645-x. EJNMMI Res. 2020. PMID: 32472232 Free PMC article.
-
A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade glioma.Neurooncol Adv. 2021 Mar 7;3(1):vdab003. doi: 10.1093/noajnl/vdab003. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34409294 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials